Development of a Novel Screening Strategy Designed to Discover a New Class of HIV Drugs (Q34435796)

2 August 2017

Development of a Novel Screening Strategy Designed to Discover a New Class of HIV Drugs (English)

1 reference

2 August 2017

0 references

7

Ronald Swanstrom

1 reference

2 August 2017

Nancy Cheng

1

1 reference

2 August 2017

Sook-Kyung Lee

2

1 reference

2 August 2017

P Scott Donover

3

1 reference

2 August 2017

Mel Reichman

4

1 reference

2 August 2017

Celia A Schiffer

5

1 reference

2 August 2017

Emily A Hull-Ryde

6

1 reference

2 August 2017

William P Janzen

8

1 reference

2 August 2017

4 December 2013

1 reference

Journal of Laboratory Automation

2 August 2017

1 reference

2 August 2017

19

1 reference

2 August 2017

3

1 reference

2 August 2017

297-303

1 reference

A sensitive assay using a native protein substrate for screening HIV-1 maturation inhibitors targeting the protease cleavage site between the matrix and capsid

2 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4216240

HIV Drug Resistance and the Advent of Integrase Inhibitors.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4216240

The choreography of HIV-1 proteolytic processing and virion assembly

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4216240

New informatics and automated infrastructure to accelerate new leads discovery by high throughput screening (HTS).

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4216240

Context surrounding processing sites is crucial in determining cleavage rate of a subset of processing sites in HIV-1 Gag and Gag-Pro-Pol polyprotein precursors by viral protease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4216240

Design and implementation of high throughput screening assays

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4216240

How to improve R&D productivity: the pharmaceutical industry's grand challenge

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4216240

Quantitative analyses of aggregation, autofluorescence, and reactivity artifacts in a screen for inhibitors of a thiol protease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4216240

Fifteen years of HIV Protease Inhibitors: raising the barrier to resistance

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4216240

A strongly transdominant mutation in the human immunodeficiency virus type 1 gag gene defines an Achilles heel in the virus life cycle

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4216240

Resilience to resistance of HIV-1 protease inhibitors: profile of darunavir.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4216240

Evaluation of an orthogonal pooling strategy for rapid high-throughput screening of proteases

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4216240

An empirical process for the design of high-throughput screening deck filters.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4216240

Small-molecule inhibition of human immunodeficiency virus type 1 replication by specific targeting of the final step of virion maturation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4216240

PA-457: A potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4216240

Guidelines for using antiretroviral agents among HIV-infected adults and adolescents

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4216240

A Common Mechanism Underlying Promiscuous Inhibitors from Virtual and High-Throughput Screening

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4216240

Lack of synergy for inhibitors targeting a multi-drug-resistant HIV-1 protease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4216240

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4216240

Fluorescence polarization and anisotropy in high throughput screening: perspectives and primer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4216240

A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4216240

Multiple drug resistance to nucleoside analogues and nonnucleoside reverse transcriptase inhibitors in an efficiently replicating human immunodeficiency virus type 1 patient strain

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4216240

Assay of proteolytic enzymes by the fluorescence polarization technique

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4216240

Impact of high-throughput screening in biomedical research

6 July 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068213513453

Fluorescence anisotropy assay for proteolysis of specifically labeled fusion proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068213513453

Statistical potentials for fold assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068213513453

Chris Lipinski discusses life and chemistry after the Rule of Five.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068213513453

Statistical evaluation of a self-deconvoluting matrix strategy for high-throughput screening of the CXCR3 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068213513453

Strategic Pooling of Compounds for High-Throughput Screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068213513453

Measurement of specific protease activity utilizing fluorescence polarization

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24305957

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Assay of Angiotensin I by Fluorescence Polarization Method

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24305957

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1177/2211068213513453

1 reference

2 August 2017

1 reference

2 August 2017

1 reference